<DOC>
	<DOCNO>NCT00150644</DOCNO>
	<brief_summary>The objective study evaluate effect 10 mg 25 mg dos asoprisnil , compare placebo , take daily 12 week , uterine blood flow morphology endometrium uterine fibroid .</brief_summary>
	<brief_title>A Study Evaluate Effects Asoprisnil ( J867 ) Women With Uterine Fibroids Who Are Scheduled Hysterectomy</brief_title>
	<detailed_description>No medical therapy currently available long-term treatment uterine fibroid . The objective study determine effect asoprisnil uterine fibroid growth suppression . Full thickness biopsy obtain surgical procedure allow assessment asoprisnil 's effect basalis , myometrium , endometrial angiogenesis . Various exploratory immunohistological biochemical specimen collect evaluate mechanism action asoprisnil endometrium , myometrium , uterine fibroid .</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>Premenopausal woman , least 18 year age Diagnosis uterine fibroid ( ) , confirm ultrasound History menstrual cycle 17 42 day Otherwise good health Scheduled hysterectomy end treatment period Negative pregnancy test Agrees double barrier method contraception Pap test evidence malignancy premalignant change Endometrial biopsy significant histological disorder Less 3 month baby breastfeed Any abnormal lab procedure result studydoctor considers important Severe reaction ( ) currently use hormone therapy History cancer alcohol drug abuse Diagnosis Polycystic Ovary Syndrome History prolactinoma Current use Intrauterine Device Significant gynecological disorder Uterine size &gt; 32 week gestation Current diagnosis endometriosis Uterine artery embolization within 6 month</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Fibroid Uterus</keyword>
	<keyword>Leiomyoma</keyword>
	<keyword>Uterine Fibroids</keyword>
	<keyword>Hysterectomy</keyword>
	<keyword>Asoprisnil</keyword>
</DOC>